Eli Lilly to invest $1 billion in new contract manufacturing facility in Hyderabad
Eli Lilly and Company will be investing more than $1 billion over the next several years into new contract manufacturing in India. It will establish a new facility for manufacturing and quality presence in Hyderabad.
This new hub will offer advanced technical capabilities and oversight for Lilly’s contract manufacturing network across India. Recruitment will begin immediately, with openings across roles such as engineers, chemists, analytical scientists, quality control and assurance professionals, and management positions.
“We are making significant investments to increase manufacturing and medicine supply capacity around the world to help ensure patients have access to the medicines they need,” , Patrik Jonsson, Executive Vice President and President, Lilly International, Eli Lilly and Company said in a release.
. “Working with trusted contract manufacturers expands our capabilities to deliver life-changing medicines at greater scale. This investment reaffirms our confidence in India as a hub for capability building within our global network,’‘ he added.
“Lilly’s continued expansion in Hyderabad highlights the city’s emergence as a powerhouse in global healthcare innovation,’’ A Revanth Reddy, Chief Minister, Telangana said,
Lilly has a longstanding presence in India, including a commercial site in Gurugram and specialized sites in Bengaluru and Hyderabad that serve as important hubs supporting global innovation.
Since 2020, Lilly has committed more than $55 billion to build, expand, and acquire facilities in the U.S. and around the world. These facilities and investments address growth from potential new medicines to treat diabetes and obesity, Alzheimer’s disease, cancer and autoimmune conditions and prepare for medicines of the future.
More Like This
Published on October 6, 2025